Non-viral Gene Delivery Technologies Market, By Product Type (Reagents & Kits, Delivery Devices, and Pre-formulated Nanoparticles), By Technology Type, By Material Type, By Delivery Target, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4043
|
Published Date
June 2025
|
Pages
378
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Non-viral Gene Delivery Technologies Market size was valued at US$ 3,768.98 Million in 2024, expanding at a CAGR of 12.5% from 2025 to 2032.
The Non-viral Gene Delivery Technologies market focuses on methods of transferring genetic material into cells without the use of viral vectors, offering enhanced safety and reduced immune responses. The growing adoption of gene therapies and personalized medicine has fueled interest in non-viral delivery systems due to their lower risk profiles and greater scalability. For instance, research highlighted by the National Institutes of Health emphasizes the increasing use of lipid nanoparticles and polymer-based carriers for efficient gene transfer. However, challenges such as lower delivery efficiency compared to viral vectors and difficulties in targeting specific tissues continue to limit broader adoption. Despite these obstacles, rising research funding, advancements in nanotechnology, and the increasing prevalence of genetic disorders present significant opportunities for innovation and commercialization. Additionally, support from government health agencies promoting safer gene therapies is driving further market growth and development.
Non-viral Gene Delivery Technologies Market- Market Dynamics
Advancements in Safer Gene Therapies to Accelerate Market Growth
Advancements in safer gene therapies have significantly accelerated the development of non-viral gene delivery technologies, providing alternatives to viral vectors that minimize risks such as immune reactions and insertional mutagenesis. The National Institutes of Health reports growing use of non-viral methods—including lipid nanoparticles and polymer-based carriers—in experimental treatments for genetic disorders and cancer. According to the U.S. Food and Drug Administration, recent regulatory approvals and ongoing clinical trials underscore increasing confidence in non-viral systems for precise gene delivery.
Moreover, these technologies enable scalable manufacturing processes and enhance patient safety, aligning with global health initiatives aimed at promoting innovative and accessible gene therapies. With governments worldwide ramping up funding for genetic research, there are expanding opportunities to apply these technologies beyond rare diseases to more common conditions, thereby advancing personalized medicine approaches.
Non-viral Gene Delivery Technologies Market- Segmentation Analysis:
The Global Non-viral Gene Delivery Technologies Market is segmented on the basis of Product Type, Technology Type, Material Type, Delivery Target, Application, and Region.
The gene delivery market is segmented into three primary product types: Reagents & Kits, Delivery Devices, and Pre-formulated Nanoparticles. Reagents and kits dominate the market due to their essential role in preparing and facilitating gene delivery processes across various therapeutic applications. Delivery devices follow closely, providing precise and controlled administration of genetic material, which is critical for maximizing treatment efficacy and minimizing off-target effects. Pre-formulated nanoparticles are gaining increasing importance as they enable targeted and efficient delivery systems, particularly in the development of non-viral gene therapies that offer safer alternatives to viral vectors. According to the U.S. National Institutes of Health (NIH), federal funding for research and development in gene delivery reagents and nanoparticle technologies increased by over 30% from 2020 to 2024, reflecting growing governmental support for innovative gene therapy platforms.
Based on technology type, the market is divided into Electroporation, Lipid-based Transfection, Polymer-based Transfection, Physical Methods (including microinjection and gene gun), and Nanoparticles such as liposomes and dendrimers. Lipid-based transfection leads the market due to its high efficiency, ease of use, and biocompatibility, making it widely adopted in both research and clinical settings. Nanoparticle-based delivery systems follow closely, offering enhanced targeting capabilities and improved cellular uptake. Electroporation is especially valued for its ability to transfect difficult-to-target cells with high efficiency. Polymer-based transfection and physical methods serve specialized niches, supporting non-viral gene delivery in complex therapeutic contexts. The U.S. Department of Energy (DOE) reported in 2023 that investments in advanced non-viral gene delivery technologies, including nanoparticle formulations and electroporation devices, rose by 25%, underscoring federal initiatives aimed at accelerating the development of next-generation gene therapies.
Non-viral Gene Delivery Technologies Market- Geographical Insights
The Non-viral Gene Delivery Technologies market exhibits notable regional differences influenced by healthcare infrastructure and research capabilities. North America remains a leading hub, driven by its advanced biotechnology industry and substantial government funding for gene therapy research. Europe closely follows, benefiting from widespread adoption of innovative therapies and supportive regulatory frameworks. The Asia-Pacific region is experiencing rapid growth, fueled by increased investments in biotechnology and a rising prevalence of genetic disorders. Countries such as China, Japan, and South Korea are prioritizing the development of manufacturing capabilities and clinical trial centers.
Meanwhile, Latin America and the Middle East represent emerging markets, marked by growing awareness and gradual improvements in healthcare access. Despite challenges like regulatory complexities and limited expertise in certain regions, collaborations between academic institutions and industry players are facilitating technology transfer and innovation on a global scale. According to data from the World Health Organization and the Global Alliance for Genomics and Health, governments worldwide have collectively increased funding for gene therapy research by over 35% since 2020, reflecting a strong commitment to advancing personalized medicine. This expanding global focus on personalized medicine and improved accessibility to gene therapies continues to shape market dynamics across these diverse regions.
Non-viral Gene Delivery Technologies Market- Competitive Landscape:
The competitive landscape of the Non-viral Gene Delivery Technologies market features a diverse mix of established biotech firms, innovative startups, and academic collaborations, all focused on improving delivery efficiency and safety. Companies are heavily investing in the development of novel lipid- and polymer-based carriers, as well as advanced nanoparticle platforms, to address the limitations of traditional viral vectors. Strategic partnerships between pharmaceutical companies and technology providers are common, aimed at accelerating product development and expanding pipeline offerings. Intellectual property and proprietary delivery technologies remain critical for maintaining competitive advantage.
Regional players across North America, Europe, and Asia are intensifying efforts to expand clinical trial activities and secure regulatory approvals to increase market share. Additionally, growing funding from government agencies and private organizations for gene therapy research is fostering innovation and intensifying competition. Continuous advancements in formulation techniques and targeted delivery systems are expected to play a pivotal role in shaping the market’s competitive dynamics in the near future.
Recent Developments:
- March 2024: PulseSight Therapeutics launched with seed funding to advance its proprietary non-viral gene delivery technology targeting severe retinal diseases. Their platform aims to enable long-lasting gene expression through minimally invasive therapies for wet and dry age-related macular degeneration.
- April 2024: Nvelop Therapeutics secured $100 million in funding to develop next-generation, programmable non-viral gene delivery platforms. Their dual in vivo-validated technologies focus on efficient, cell-specific delivery of genetic medicines for a wide range of previously untreatable diseases.
- June 2024: DNA Nanobots obtained an exclusive license from UC Berkeley for a novel non-viral gene delivery platform that combines DNA nanoparticles with CRISPR-Cas technology. This innovation enables efficient, targeted gene editing and therapy, with applications in rare diseases and cancer treatment.
- February 2025: Genprex advanced its diabetes gene therapy program through a collaboration with a contract development and manufacturing organization (CDMO) to develop a non-viral lipid nanoparticle delivery system. This next-generation approach aims to offer re-dosable gene therapy options with advantages over traditional viral-based methods.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Altogen Biosystems
- BioCubaFarma
- Bio-Techne (formerly B-MoGen)
- Evonik Industries AG
- GenScript
- MaxCyte, Inc.
- Mirus Bio
- Nitto Denko Avecia
- Polyplus-transfection
- Polypus Therapeutics
- Poseida Therapeutics
- Precision NanoSystems
- Sigma-Aldrich (Merck KGaA)
- SIRION Biotech (PerkinElmer)
- Takeda
- Thermo Fisher Scientific
- Others
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Delivery Devices
- Pre-formulated Nanoparticles
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032
- Electroporation
- Lipid-based Transfection
- Polymer-based Transfection
- Physical Methods (microinjection, gene gun)
- Nanoparticles (liposomes, dendrimers)
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032
- Lipids
- Polymers
- Inorganic Materials (Gold, Silica)
- Peptides
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY DELIVERY TARGET- MARKET ANALYSIS, 2019 - 2032
- In Vitro
- In Vivo
- Ex Vivo
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Gene Therapy
- DNA Vaccines
- RNA Interference (RNAi)
- CRISPR/Cas9 Gene Editing
- Protein Expression
GLOBAL NON-VIRAL GENE DELIVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Non-viral Gene Delivery Technologies Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Non-viral Gene Delivery Technologies Market Snippet by Product Type
2.1.2. Non-viral Gene Delivery Technologies Market Snippet by Technology Type
2.1.3. Non-viral Gene Delivery Technologies Market Snippet by Material Type
2.1.4. Non-viral Gene Delivery Technologies Market Snippet by Delivery Target
2.1.5. Non-viral Gene Delivery Technologies Market Snippet by Application
2.1.6. Non-viral Gene Delivery Technologies Market Snippet by Country
2.1.7. Non-viral Gene Delivery Technologies Market Snippet by Region
2.2. Competitive Insights
3. Non-viral Gene Delivery Technologies Key Market Trends
3.1. Non-viral Gene Delivery Technologies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Non-viral Gene Delivery Technologies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Non-viral Gene Delivery Technologies Market Opportunities
3.4. Non-viral Gene Delivery Technologies Market Future Trends
4. Non-viral Gene Delivery Technologies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Non-viral Gene Delivery Technologies Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Non-viral Gene Delivery Technologies Market Landscape
6.1. Non-viral Gene Delivery Technologies Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Non-viral Gene Delivery Technologies Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Reagents & Kits
7.1.3. Delivery Devices
7.1.4. Pre-formulated Nanoparticles
8. Non-viral Gene Delivery Technologies Market – By Technology Type
8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
8.1.2. Electroporation
8.1.3. Lipid-based Transfection
8.1.4. Polymer-based Transfection
8.1.5. Physical Methods (microinjection, gene gun)
8.1.6. Nanoparticles (liposomes, dendrimers)
9. Non-viral Gene Delivery Technologies Market – By Material Type
9.1. Overview
9.1.1. Segment Share Analysis, By Material Type, 2024 & 2032 (%)
9.1.2. Lipids
9.1.3. Polymers
9.1.4. Inorganic Materials (Gold, Silica)
9.1.5. Peptides
10. Non-viral Gene Delivery Technologies Market – By Delivery Target
10.1. Overview
10.1.1. Segment Share Analysis, By Delivery Target, 2024 & 2032 (%)
10.1.2. In Vitro
10.1.3. In Vivo
10.1.4. Ex Vivo
11. Non-viral Gene Delivery Technologies Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
11.1.2. XX
11.1.3. XX
11.1.4. XX
12. Non-viral Gene Delivery Technologies Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Non-viral Gene Delivery Technologies Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Non-viral Gene Delivery Technologies Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Non-viral Gene Delivery Technologies Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Non-viral Gene Delivery Technologies Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Non-viral Gene Delivery Technologies Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Target, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Non-viral Gene Delivery Technologies Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Altogen Biosystems
13.2.2. BioCubaFarma
13.2.3. Bio-Techne (formerly B-MoGen)
13.2.4. Evonik Industries AG
13.2.5. GenScript
13.2.6. MaxCyte, Inc.
13.2.7. Mirus Bio
13.2.8. Nitto Denko Avecia
13.2.9. Polyplus-transfection
13.2.10. Polypus Therapeutics
13.2.11. Poseida Therapeutics
13.2.12. Precision NanoSystems
13.2.13. Sigma-Aldrich (Merck KGaA)
13.2.14. SIRION Biotech (PerkinElmer)
13.2.15. Takeda
13.2.16. Thermo Fisher Scientific
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
